Evidence map›Paper›PMID 19807189›Full record

ArticleJournal of the American Chemical Society2009

Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals.

Colin A Lowery, Junguk Park, Christian Gloeckner, Michael M Meijler, Ryan S Mueller, Helena I Boshoff, Ricky L Ulrich, Clifton E Barry, Douglas H Bartlett, Vladimir V Kravchenko and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 84 citations in OpenAlex.

  1. Arcopilins: A New Family ofJournal of medicinal chemistry · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Antimicrobial Weapons of Pseudomonas aeruginosa.Advances in experimental medicine and biology · 2022
    Article
  6. Article
  7. Article
  8. Adaptive Interactions ofPathogens (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Colin A LoweryDepartment of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Junguk Park
Christian Gloeckner
Michael M Meijler
Ryan S Mueller
Helena I Boshoff
Ricky L Ulrich
Clifton E Barry
Douglas H Bartlett
Vladimir V Kravchenko
Gunnar F Kaufmann
Kim D Janda
Scripps Research Institute · US

Funding

Bacterial Quorum Sensing as Target for Anti-Infective ImmunotherapyR01AI080715 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ZHOU, BIN · 2009 to 2013
$2.3M
Biological Implications of Tetramic AcidR21AI079503 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI JANDA, KIM · 2009 to 2010
$522k
Modulation of the innate immunity by bacterial signaling moleculesR21AI079436 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI KRAVCHENKO, VLADIMIR V · 2008 to 2009
$521k
Intramural NIH HHSNIAID NIH HHS AI079436NIAID NIH HHS AI079503NIAID NIH HHS AI080715NIAID NIH HHS HHSN272200700055CNIAID NIH HHS R01 AI080715NIAID NIH HHS R21 AI079436NIAID NIH HHS R21 AI079503
6 · The paper itself

Abstract

In nature, bacteria rarely exist as single, isolated entities, but rather as communities comprised of many other species including higher host organisms. To survive in these competitive environments, microorganisms have developed elaborate tactics such as the formation of biofilms and the production of antimicrobial toxins. Recently, it was discovered that the gram-negative bacterium Pseudomonas aeruginosa , an opportunistic human pathogen, produces an antibiotic, 3-(1-hydroxydecylidene)-5-(2-hydroxyethyl)pyrrolidine-2,4-dione (C(12)-TA), derived from one of its quorum sensing molecules. Here, we present a comprehensive study of the expanded spectrum of C(12)-TA antibacterial activity against microbial competitors encountered by P. aeruginosa in nature as well as significant human pathogens. The mechanism of action of C(12)-TA was also elucidated, and C(12)-TA was found to dissipate both the membrane potential and the pH gradient of Gram-positive bacteria, correlating well with cell death. Notably, in stark contrast to its parent molecule 3-oxo-dodecanoyl homoserine lactone (3-oxo-C(12)-HSL), neither activation of cellular stress pathways nor cytotoxicity was observed in human cells treated with C(12)-TA. Our results suggest that the QS machinery of P. aeruginosa has evolved for a dual-function, both to signal others of the same species and also to defend against host immunity and competing bacteria. Because of the broad-spectrum antibacterial activity, established mode of action, lack of rapid resistance development, and tolerance by human cells, the C(12)-TA scaffold may also serve as a new lead compound for the development of antimicrobial therapeutics.

Indexed as

4-ButyrolactoneAnti-Bacterial AgentsGram-Positive BacteriaHumansMembrane PotentialsMicrobial Sensitivity TestsPseudomonas aeruginosaPyrrolidinesPyrrolidinonesQuorum Sensing4-ButyrolactoneAnti-Bacterial Agentshomoserine lactonePyrrolidinesPyrrolidinonestetramic acid

Identifiers

PMID19807189
PMCPMC2760024
OpenAlexW2112592064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.